Discovering novel natural products from fungal species
Ended Project Grant Awarded Last action
- Award ID
- R43GM154504
- Recipient
-
Chemia Biosciences, Inc. UEI F91YML3Q7YU3
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $308,925
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Place of performance
- Pennsylvania, USA
Award details come from USAspending.gov.
Description
- Abstract
- Antibiotic resistance is becoming a major public health problem worldwide, with antibiotic resistant pathogens infecting hundreds of millions and killing over a million patients worldwide each year. Infections such as pneumonia, tuberculosis, blood poisoning, gonorrhoea, and foodborne diseases are becoming harder or impossible to treat with the existing medicine. Majority of antibiotics currently in clinical use are natural products or their derivatives. However, recently discovery of natural products with novel mechanisms to kill pathogens have become more challenging due to the high rate of rediscovery of known molecules, as the traditional technologies only capture the highest abundant molecular products of microbial isolates. The introduction of modern sequencing technologies and genome mining in early 2000 has revolutionized the field of natural product discovery. While these technologies have revealed millions of biosynthetic gene clusters (bgcs, clusters of genes that encode for natural products) in microbial genomes, currently these methods cannot predict the precise action of enzymes in bgcs, and therefore fail to correctly predict the final molecular product of bgcs. Chemia biosciences is developing technologies to predict the molecular product of these bgcs based on high- throughput mass spectrometry data collected on extracts of microbial cultures. In the past, the PI and CO-PI have developed techniques for identifying known and discovering novel bacterial natural products by a computational analysis of mass spectrometry data. The main goal of this proposal is to develop methods for discovering novel fungal natural products, a biomedically important class of natural products that include antibacterial penicillin, antifungal echinocandin, anticancer paclitaxel, immunosuppressant cyclosporin, and cholesterol-lowering medication lovastatin. The software developed in the course of this proposal will be available to partners as a cloud service.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $308,925 |
Quick answers
Who received award R43GM154504?
R43GM154504 was awarded to Chemia Biosciences, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on September 1, 2024.
How much is award R43GM154504 worth?
$308,925 has been obligated on R43GM154504.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award